Urgent.News

600+ sources. One page. See who else covered it.

Editions

Health & Medicine

People With Disabilities Fear Service Cuts as Trump’s DOJ Questions Legal Protections

The Department of Justice in June issued a legal opinion saying states aren’t required to provide services that help people with disabilities remain in their homes. The new position has added momentum to states’ existing legal challenges to the requirement and triggered worries among people who rely on these services.

People With Disabilities Fear Service Cuts as Trump’s DOJ Questions Legal Protections

Advocates for people with disabilities fear that the Trump administration's Department of Justice (DOJ) opinion could lead to cuts in services for those reliant on home healthcare. Amanda DeSimone-Shabrack, whose autistic son Mason requires assistance, warns that the DOJ's legal stance could mean her son must be institutionalized.

The DOJ's opinion contradicts a 1999 Supreme Court ruling, which established that unjustified institutionalization is discriminatory under the Americans with Disabilities Act (ADA). Former administrations used the ADA interpretation to enforce civil rights for disabled individuals, but the Trump administration contends this interpretation is incorrect.

Disability rights groups express concern that the new interpretation may lead to a return to forced institutionalization for about 40 million adults and 5 million children with disabilities. The stage is set for a legal battle between advocates, states, and the federal government. Some states have already cited the DOJ opinion in lawsuits challenging disability rights requirements, citing it as evidence that integration mandates are costly and infringe on states' rights.

Advocacy groups fear the DOJ opinion could undermine existing laws and regulations that mandate community-based services for disabled individuals, potentially leading to a rollback of Medicaid services that enable people to stay in their homes. Democrats have criticized the DOJ's memo, portraying it as an attack on the rights and independence of the disability community, and introduced a resolution calling for the DOJ to rescind the opinion.

Written by urgent.news from KFF Health News's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.

Also reported by 1 other outlet

Read the original at kffhealthnews.org →

More in Health & Medicine

Celltrion ADC Candidates Win FDA Fast Track

All three antibody-drug conjugate (ADC)-based anticancer new drug candidates being developed by Celltrion have been named targets for the Fast Track designation by the U.S.

  • Celltrion secures FDA Fast Track designation for three ADC candidates.
  • CT-P73 targets recurrent and metastatic cervical cancer.
  • Designation aims to expedite development and commercialization.

Novo Nordisk FDA Setback Creates Opportunity for Korean CDMOs

Denmark’s Novo Nordisk, which has led the global pharmaceutical and biotech market on the back of explosive demand for the obesity treatments Wegovy and Ozempic, has run into an unexpected hurdle as…

  • FDA withholds approval for Novo Nordisk facilities due to quality-control violations.
  • Novo Nordisk's Bloomington facility received critical observations, including sterility failures.
  • Korean CDMOs like Celltrion and Samsung Biologics benefit from regulatory challenges.